Follow
Ainoleena Turku
Ainoleena Turku
Orion Corporation
Verified email at orionpharma.com
Title
Cited by
Cited by
Year
Structural insight into small molecule action on Frizzleds
P Kozielewicz, A Turku, CF Bowin, J Petersen, J Valnohova, MCA Cañizal, ...
Nature communications 11 (1), 414, 2020
462020
Molecular pharmacology of class F receptor activation
P Kozielewicz, A Turku, G Schulte
Molecular pharmacology 97 (2), 62-71, 2020
312020
Cryo-EM structure of constitutively active human Frizzled 7 in complex with heterotrimeric Gs
L Xu, B Chen, H Schihada, SC Wright, A Turku, Y Wu, GW Han, ...
Cell research 31 (12), 1311-1314, 2021
272021
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity
A Turku, MK Rinne, G Boije af Gennäs, H Xhaard, D Lindholm, ...
PLoS One 12 (6), e0178526, 2017
262017
Deconvolution of WNT-induced Frizzled conformational dynamics with fluorescent biosensors
H Schihada, M Kowalski-Jahn, A Turku, G Schulte
Biosensors and Bioelectronics 177, 112948, 2021
242021
Azulene-based compounds for targeting orexin receptors
TO Leino, A Turku, J Yli-Kauhaluoma, JP Kukkonen, H Xhaard, ...
European Journal of Medicinal Chemistry 157, 88-100, 2018
242018
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands
A Turku, A Borrel, TO Leino, L Karhu, JP Kukkonen, H Xhaard
Journal of Medicinal Chemistry 59 (18), 8263-8275, 2016
232016
A NanoBRET-based binding assay for smoothened allows real-time analysis of ligand binding and distinction of two binding sites for BODIPY-cyclopamine
P Kozielewicz, CF Bowin, A Turku, G Schulte
Molecular pharmacology 97 (1), 23-34, 2020
222020
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine
Y Zhou, GH Arribas, A Turku, T Jürgenson, S Mkrtchian, K Krebs, Y Wang, ...
Science Advances 7 (36), eabi6856, 2021
212021
Modeling of the OX1R–orexin-A complex suggests two alternative binding modes
L Karhu, A Turku, H Xhaard
BMC structural biology 15, 1-17, 2015
212015
Asymmetry in catalysis by Thermotoga maritima membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitor
K Vidilaseris, A Kiriazis, A Turku, A Khattab, NG Johansson, TO Leino, ...
Science Advances 5 (5), eaav7574, 2019
202019
Insights into the mechanism of membrane pyrophosphatases by combining experiment and computer simulation
NR Shah, C Wilkinson, SPD Harborne, A Turku, KM Li, YJ Sun, S Harris, ...
Structural Dynamics 4 (3), 2017
202017
Frizzled BRET sensors based on bioorthogonal labeling of unnatural amino acids reveal WNT-induced dynamics of the cysteine-rich domain
M Kowalski-Jahn, H Schihada, A Turku, T Huber, TP Sakmar, G Schulte
Science Advances 7 (46), eabj7917, 2021
192021
Residue 6.43 defines receptor function in class F GPCRs
A Turku, H Schihada, P Kozielewicz, CF Bowin, G Schulte
Nature Communications 12 (1), 3919, 2021
162021
Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26
MK Rinne, TO Leino, A Turku, PM Turunen, Y Steynen, H Xhaard, ...
European Journal of Pharmacology 837, 137-144, 2018
142018
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C
R Provenzani, I Tarvainen, G Brandoli, A Lempinen, S Artes, A Turku, ...
PLoS One 13 (4), e0195668, 2018
122018
Structure–Activity Relationships of 1‐Benzoylazulenes at the OX1 and OX2 Orexin Receptors
A Turku, TO Leino, L Karhu, J Yli‐Kauhaluoma, JP Kukkonen, ...
ChemMedChem 14 (9), 965-981, 2019
112019
Discovery of membrane-bound pyrophosphatase inhibitors derived from an isoxazole fragment
NG Johansson, A Turku, K Vidilaseris, L Dreano, A Khattab, ...
ACS Medicinal Chemistry Letters 11 (4), 605-610, 2020
102020
Defining dynamics of membrane-bound pyrophosphatases by experimental and computational single-molecule fret
SPD Harborne, J Strauss, A Turku, MA Watson, R Tuma, SA Harris, ...
Methods in Enzymology 607, 93-130, 2018
42018
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
K Vidilaseris, NG Johansson, A Turku, A Kiriazis, GB af Gennäs, ...
JoVE (Journal of Visualized Experiments), e60619, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20